Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD
Clinical Journal of the American Society of Nephrology Nov 09, 2017
Bushinsky DA, et al. - Researchers in this study determined the efficacy and safety of TRC101, a novel, sodium-free, nonabsorbed hydrochloric acid binder, to increase serum bicarbonate in patients with chronic kidney disease and metabolic acidosis. As per findings, TRC101 safely and significantly increased the level of serum bicarbonate in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries